Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 Î¼g of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess Safety